Clinical Trials Directory

Trials / Completed

CompletedNCT01480349

Shunt Outcomes of Post-Hemorrhagic Hydrocephalus

Shunt Outcomes of Post-Hemorrhagic Hydrocephalus: A Network Pilot Study

Status
Completed
Phase
Study type
Observational
Enrollment
146 (actual)
Sponsor
University of Utah · Academic / Other
Sex
All
Age
180 Days
Healthy volunteers
Not accepted

Summary

This multicenter, prospective pilot study will compare the effectiveness of two established procedures used in the treatment of post-hemorrhagic hydrocephalus in very low birth weight infants, specifically ventricular reservoirs and subgaleal shunts. The study is being conducted by the Hydrocephalus Clinical Research Network (HCRN), a network established to conduct multi-institutional clinical trials on pediatric hydrocephalus.

Detailed description

Intraventricular hemorrhage and post-hemorrhagic hydrocephalus remain a leading cause of mortality and long-term morbidity in premature infants. The two most common temporary cerebrospinal fluid (CSF) diversion procedures are the ventriculosubgaleal shunt (SGS) and an implanted ventricular reservoir (RES) for intermittent CSF removal. These methods are physiologically very different and their comparative effectiveness in treating hydrocephalus and possibly reducing the need for an eventual permanent CSF shunt is currently not known. The goal of this pilot study is to obtain information critical for planning and executing a future randomized trial comparing SGS and RES. Specifically, this pilot study will establish inclusion criteria, define the primary outcome, and standardize the interventions in preparation for initiating a comparative trial between the SGS and RES procedures. In addition, the importance of examining the neurodevelopmental outcomes for these patients has been recognized within the neurosurgical and neuropsychological settings. Therefore, the scope of this study has been extended to include an examination of the neurodevelopmental outcomes at 18 to 22 months and at 36 to 42 months in patients who undergo BSID-III testing at their clinical centers.

Conditions

Timeline

Start date
2011-01-10
Primary completion
2016-05-10
Completion
2016-05-10
First posted
2011-11-28
Last updated
2017-12-26

Locations

7 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT01480349. Inclusion in this directory is not an endorsement.